Skip to main content
. 2018 Jan 16;178(3):328–337. doi: 10.1001/jamainternmed.2017.7978

Table 4. Unadjusted and Adjusted Relative Hazards of Incident Diabetes During Follow-up From 1986 to 2016 Among Lactation Duration Categories.

Multivariate Models Time-Dependent Lactation Duration Categories, Adjusted Relative Hazard (95% CI) P Value for Trenda
None
(n = 322)
>0 to 6 mo (n = 418) >6 to <12 mo (n = 268) ≥12 mo (n = 230)
Model 1 Unadjusted 1 [Reference] 0.60 (0.43-0.83) 0.36 (0.23-0.57) 0.29 (0.17-0.49) <.001
Model 2 (model 1 plus adjustment for race time-dependent parity and GD status during follow-up) 1 [Reference] 0.74 (0.53-1.04) 0.55 (0.34-0.87) 0.45 (0.26-0.80) .003
Model 3 (model 2 plus age, baseline covariates [body mass index,b waist circumference, and fasting glucosec], and familiy history of diabetes) 1 [Reference] 0.84 (0.60-1.20) 0.56 (0.35-0.91) 0.50 (0.27-0.90) .006
Model 4 (model 3 plus time-dependent physical activity scored and Diet Quality scoree during follow-up) 1 [Reference] 0.81 (0.56-1.19) 0.53 (0.31-0.88) 0.53 (0.29-0.98) .01
Model 5 (model 4 plus time-dependent weight changef during follow-up) 1 [Reference] 0.75 (0.51-1.09) 0.52 (0.31-0.87) 0.53 (0.29-0.98) .01

Abbreviation: GD, gestational diabetes.

a

No evidence of effect modification by race, GD status, or parity groups.

b

Calculated as weight in kilograms divided by height in meters squared.

c

Fasting serum glucose at baseline (year 0); there was missing data for 5 participants, and 10 participants had fasting glucose from year 7 before diabetes onset (all values at year 7 <100 mg/dL).

d

Quartiles for time-dependent physical activity score for race-specific quartiles were evaluated as the average of scores from years 0, 7, and 20 (19 women were missing follow-up physical activity score).

e

Quartiles for the a priori Diet Quality score were evaluated as the average of scores from years 0, 7, and 20 (10 women were missing average Diet Quality score).

f

Time-dependent weight change equals weight change above the median vs at or below from baseline through the end of follow-up.